Gene Therapy Brings Functional Cure to Sickle Cell Patients

Twenty-seven out of 28 patients with severe sickle cell disease are now living pain-free after a groundbreaking gene editing treatment.

The one-time therapy is offering new hope to people living with a genetic disorder that typically shortens life expectancy to the mid-40s.